Frontlight ResearchEarly access
Trial site
Onkologicky ustav sv. Alzbety, s.r.o.
- 8running trials
- 3closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Conditions
- Metastatic breast cancer8 trials
- Childhood cancers2 trials
- Colorectal cancer2 trials
- Lung cancer2 trials
- Prostate cancer2 trials
- Endometrial cancer1 trial
- Gastric and oesophageal cancer1 trial
- Head and neck cancer1 trial
- Kidney cancer1 trial
- Liver and biliary tract cancer1 trial
- Melanoma1 trial
- Ovarian cancer1 trial
- and 3 more
- Phase
- Phase 38 trials
- Phase 22 trials
- Phase 11 trial
- Status
- Active, not recruiting5 trials
- Completed2 trials
- Not yet recruiting2 trials
- Recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Pfizer6 trials
- Novartis Pharmaceuticals2 trials
- AstraZeneca1 trial
- Gilead Sciences1 trial
- Novartis Pharma AG1 trial
Running trials
Not yet recruiting
Not yet recruiting
Roll-Over Study of Alpelisib (BYL719) for Continued Access and Long-Term Safety.
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Metastatic breast cancer2 recruiting
- Childhood cancers1 recruiting
- Prostate cancer1 recruiting
Closed trials
Active, not recruiting
Active, not recruiting
Terminated
Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors.
Site data: ClinicalTrials.govUpdated 17 Nov 2026